Fibromyalgia patients’ satisfaction with their treatment is predictable through consideration of pre-treatment, patient-specific factors, according to a study in the journal Clinical and Experimental ...

The condition is best understood as a symptom-based disorder of altered pain processing with partial overlap with post-viral ...

May 12 is National Fibromyalgia Awareness Day. Fibromyalgia is a disorder caused by the brain perceiving normal sensations as pain due to the enhancement of peripheral sensory signals. The disorder ...

CLEVELAND, Ohio (WOIO) - A new therapy is giving hope and relief to chronic pain sufferers, the likes of which they’ve never seen, delivering a 50% reduction in pain. This technology that’s helping ...

Patients suffering from a condition characterized by pain and fatigue could find relief in the form of oral THC treatment, according to newly published research. The study, published in the German ...

Fibromyalgia candidate TNX-102 SL hits primary endpoint of daily pain reduction (p=0.00005)Combination of broad-spectrum relief and favorable tolerability seen as distinguishing, competitive ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

BIRMINGHAM, UK – Widespread pain, feeling persistently tired or run down, with multiple referrals for seemingly unrelated complaints over many years are potential signs that the patient sitting in ...

A retrospective analysis of data from the US National Inpatient Sample revealed the prevalence of fibromyalgia and chronic fatigue syndrome was significantly increased in patients with IBS compared ...

University of Colorado Boulder researchers have discovered a brain signature that identifies fibromyalgia sufferers with 93 percent accuracy, a potential breakthrough for future clinical diagnosis and ...

For nearly three-quarters of obese patients with fibromyalgia, drastic caloric restriction in a small trial led to 30% or greater reduction in symptom severity in only 3 weeks, researchers reported.